临床试验/NCT06952855

NCT06952855已完成不适用

Observational Study to Evaluate Effectiveness, Safety and Satisfaction Level of Zastaprazan (JAQBO®) Under Daily Treatment for Patients With Erosive Gastroesophageal Reflux Disease

Jeil Pharmaceutical Co., Ltd.1 个研究点分布在 1 个国家目标入组 5,536 人开始时间: 2024年11月1日最近更新: 2025年5月13日

试验速览

阶段: 不适用
状态: 已完成
发起方: Jeil Pharmaceutical Co., Ltd.
入组人数: 5,536
试验地点: 1
主要终点: Change in GERD (heartburn, acid regurgitation) score in RDQ

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

This observational study is a prospective, multi-institutional non intervention study to examine the prescription patterns, corresponding treatment effects and safety in routine clinical practice for patients prescribed for the treatment of gastroesophageal reflux disease.

详细描述

The present observational study is designed to check effect and safety for patients who have been prescribed JAQBO for the treatment of erosive gastroesophageal reflux disease.

研究设计

研究类型: Observational
观察模型: Other
时间视角: Prospective

入排标准

年龄范围: 19 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•An adult over 19 years of age
•A person who voluntarily provides written informed consent

排除标准

•A pregnant woman or a nursing woman
•A person who is deemed unsuitable for the subject of the study

结局指标

主要结局

Change in GERD (heartburn, acid regurgitation) score in RDQ

时间窗: 4 weeks

Scale(none / 1day / 2day/ 3-4 day / 5-6 day/ every day)

次要结局

未报告次要终点

研究者

发起方

Jeil Pharmaceutical Co., Ltd.

申办方类型

Industry

责任方

Sponsor

研究点 (1)

Loading locations...

相似试验

已完成

不适用

Observational Study of Vismodegib (Erivedge) in Patients Treated in ArgentinaBasal Cell Carcinoma

NCT02438644Hoffmann-La Roche75

已完成

不适用

Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical PracticePlaque Psoriasis

NCT04203693Almirall, S.A.331

招募中

不适用

Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or DyslipidemiaDiabetes Mellitus, Type 2

NCT06647888Daewoong Pharmaceutical Co. LTD.12,000

Unknown

不适用

Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of AgeCOVID-19

NCT04474457Ministry of Health, Turkey1,000

已完成

不适用

Observational Study to Evaluate the Efficacy and Safety of TeneligliptinType 2 Diabetes Mellitus

NCT03793023Handok Inc.2,983